TXN Stock Analysis: Texas Instruments | NASDAQ
Semiconductors | NASDAQ, USA | Market Cap: 254.577m USD | 12M Return: 59.2% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 2.26B
EPS Trend: -41.2%
Qual. Beats: 2
Rev. Trend: 39.9%
Qual. Beats: 2
Warnings
No concerns identified
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Texas Instruments Incorporated (NASDAQ: TXN) is a Dallas-based semiconductor company founded in 1930 that designs, manufactures, and sells chips to electronics designers and manufacturers worldwide. It reports through two segments: Analog, which covers power management and signal chain products such as regulators, amplifiers, data converters, and interface devices, and Embedded Processing, which offers microcontrollers, connectivity and radar products, and applications processors. The portfolio also includes DLP imaging chips, calculators, and application-specific integrated circuits, sold into industrial, automotive, personal electronics, communications, and enterprise end markets.
The company reaches customers through a direct sales force, distributors, and its website, with geographic exposure spanning the United States, China, the rest of Asia, Europe, the Middle East, Africa, and Japan. Classified in the GICS Semiconductors sub-industry within Information Technology, TXN is a mega-cap constituent of the U.S. equity market and has been publicly traded since 1953.
- Industrial and automotive demand recovery lifts Analog segment margins
- China revenue exposure remains key risk amid semiconductor trade restrictions
- 300mm fab expansion drives capital returns trade-off versus near-term cash flow
| Net Income: 6.05b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 10.62 > 1.0 |
| NWC/Revenue: 64.32% < 20% (prev 71.92%; Δ -7.59% < -1%) |
| CFO/TA 0.24 > 3% & CFO 8.67b > Net Income 6.05b |
| Net Debt (7.73b) to EBITDA (9.46b): 0.82 < 3 |
| Current Ratio: 4.86 > 1.5 & < 3 |
| Outstanding Shares: last quarter (920.0m) vs 12m ago 0.88% < -2% |
| Gross Margin: 58.33% > 18% (prev 58.03%; Δ 0.30% > 0.5%) |
| Asset Turnover: 54.94% > 50% (prev 47.73%; Δ 7.21% > 0%) |
| Interest Coverage Ratio: 12.86 > 6 (EBIT TTM 7.25b / Interest Expense TTM 564.0m) |
| A: 0.35 (Total Current Assets 15.8b - Total Current Liabilities 3.24b) / Total Assets 35.9b |
| B: 1.48 (Retained Earnings 53.2b / Total Assets 35.9b) |
| C: 0.20 (EBIT TTM 7.25b / Avg Total Assets 35.4b) |
| D: 1.01 (Book Value of Equity 18.0b / Total Liabilities 17.9b) |
| Altman-Z'' = 9.55 = AAA |
| DSRI: 0.55 (Receivables 2.52b/3.96b, Revenue 19.5b/16.7b) |
| GMI: 0.99 (GM 58.03% / 58.33%) |
| AQI: 0.98 (AQ_t 0.23 / AQ_t-1 0.23) |
| SGI: 1.17 (Revenue 19.5b / 16.7b) |
| TATA: -0.07 (NI 6.05b - CFO 8.67b) / TA 35.9b) |
| Beneish M = -3.30 (Cap -4..+1) = AA |
As of August 05, 2026, the stock is trading at USD 283.63 with a total of 8,961,937 shares traded. Over the past week, the price has changed by +2.89%, over one month by -6.07%, over three months by +2.01% and over the past year by +59.24%.
Current recommended Stop Loss: 263.70 (which is 7% or 1.5 ATR below the current price).
Texas Instruments has received a consensus analysts rating of 3.70. Therefore, it is recommended to hold TXN.
- StrongBuy: 14
- Buy: 2
- Hold: 19
- Sell: 0
- StrongSell: 2
| Analysts Target Price | 324.5 | 14.4% |
P/E Trailing = 41.1758
P/E Forward = 33.8983
P/S = 13.0868
P/B = 13.7593
P/EG = 1.1962
Revenue TTM = 19.5b USD
EBIT TTM = 7.25b USD
EBITDA TTM = 9.46b USD
Long Term Debt = 12.9b USD (from longTermDebt, last quarter)
Short Term Debt = 1.15b USD (from shortTermDebt, last quarter)
Debt = 14.7b USD (from shortLongTermDebtTotal, last quarter) + Leases 681.0m
Net Debt = 7.73b USD (calculated: Debt 14.7b - CCE 7.00b)
Enterprise Value = 262b USD (255b + Debt 14.7b - CCE 7.00b)
Interest Coverage Ratio = 12.86 (Ebit TTM 7.25b / Interest Expense TTM 564.0m)
EV/FCF = 48.98x (Enterprise Value 262b / FCF TTM 5.36b)
FCF Yield = 2.04% (FCF TTM 5.36b / Enterprise Value 262b)
FCF Margin = 27.53% (FCF TTM 5.36b / Revenue TTM 19.5b)
Net Margin = 31.11% (Net Income TTM 6.05b / Revenue TTM 19.5b)
Gross Margin = 58.33% ((Revenue TTM 19.5b - Cost of Revenue TTM 8.11b) / Revenue TTM)
Gross Margin QoQ = 61.36% (prev 58.01%)
Tobins Q-Ratio = 7.31 (Enterprise Value 262b / Total Assets 35.9b)
Interest Expense / Debt = 3.83% (Interest Expense 564.0m / Debt 14.7b)
Taxrate = 12.39% (856.0m / 6.91b)
NOPAT = 6.36b (EBIT 7.25b * (1 - 12.39%))
Current Ratio = 4.86 (Total Current Assets 15.8b / Total Current Liabilities 3.24b)
Debt / Equity = 0.82 (Debt 14.7b / totalStockholderEquity, last quarter 18.0b)
Debt / EBITDA = 0.82 (Net Debt 7.73b / EBITDA 9.46b)
Debt / FCF = 1.44 (Net Debt 7.73b / FCF TTM 5.36b)
Total Stockholder Equity = 16.9b (last 4 quarters mean from totalStockholderEquity)
RoA = 17.09% (Net Income 6.05b / Total Assets 35.9b)
RoE = 35.77% (Net Income TTM 6.05b / Total Stockholder Equity 16.9b)
RoCE = 24.32% (EBIT 7.25b / Capital Employed (Equity 16.9b + L.T.Debt 12.9b))
RoIC = 19.37% (NOPAT 6.36b / Invested Capital 32.8b)
WACC = 10.91% (E(255b)/V(269b) * Re(11.35%) + D(14.7b)/V(269b) * Rd(3.83%) * (1-Tc(0.12)))
Discount Rate = 11.35% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -37.60 | Cagr: 0.15%
[DCF] Terminal Value 70.14% ; FCFF base≈3.81b ; Y1≈4.37b ; Y5≈6.43b
[DCF] Fair Price = 64.45 (EV 66.6b - Net Debt 7.73b = Equity 58.9b / Shares 913.2m; r=10.91% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -41.21 | EPS CAGR: -5.88% | SUE: 2.04 | # QB: 2
Revenue Correlation: 39.92 | Revenue CAGR: 3.07% | SUE: 2.24 | # QB: 2
EPS current Quarter (2026-09-30): EPS=2.42 | Chg30d=+13.92% | Revisions=+88% | Analysts=24
EPS current Year (2026-12-31): EPS=8.50 | Chg30d=+10.84% | Revisions=+91% | GrowthEPS=+56.0% | GrowthRev=+23.9%
EPS next Year (2027-12-31): EPS=10.03 | Chg30d=+12.86% | Revisions=+90% | GrowthEPS=+18.1% | GrowthRev=+13.3%
[Analyst] Revisions Ratio: +96% (up=78, down=0)